Compounds > itraconazole

itraconazole and Angiogenesis, Pathologic

itraconazole has been researched along with Angiogenesis, Pathologic in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Ahn, C; Brekken, RA; Chembukar, V; DeBerardinis, RJ; Do, QN; Fattah, FJ; Faubert, B; Gerber, DE; Kallem, RR; Kasiri, S; Kernstine, KH; Kim, J; Leff, RD; Lenkinski, RE; Padmanabhan, C; Pedrosa, I; Pelosof, L; Putnam, WC; Reznik, SI; Saltarski, JM; Skelton, R; Subramaniyan, I; Xi, Y; Yuan, Q1
El-Khordagui, LK; El-Moslemany, RM; El-Sheridy, NA; Helmy, MW; Ramadan, AA1
Chen, S; Dai, Y; Lu, Y; Mu, C; Pradhan, S; Ran, X; Ran, Y; Sun, K; Xu, X; Yang, Q; Zeng, J; Zheng, B; Zhuang, K1
Aftab, BT; Dobromilskaya, I; Liu, JO; Rudin, CM1
Liu, JO; Nacev, BA1
Dell, A; Grassi, P; Haslam, SM; Liu, JO; Nacev, BA1
Balzan, S; Beffy, P; Carluccio, MA; Carpi, A; Del Carratore, R; Giorgetti, L; Iervasi, G; Lubrano, V; Maserti, BE; Simili, M1
Naqvi, SH; Sheikh, A; Sheikh, K1
Bhat, S; Chong, CR; Liu, JO; Lu, J; Sullivan, DJ; Xu, J1

Trials

1 trial(s) available for itraconazole and Angiogenesis, Pathologic

ArticleYear
Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 11-15, Volume: 26, Issue:22

    Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Biopsy; Carcinoma, Non-Small-Cell Lung; Female; Hedgehog Proteins; Humans; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Patched-1 Receptor; Zinc Finger Protein GLI1

2020

Other Studies

8 other study(ies) available for itraconazole and Angiogenesis, Pathologic

ArticleYear
Enhancing the
    Drug delivery, 2021, Volume: 28, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Combinations; Drug Liberation; Female; Hedgehog Proteins; Humans; Itraconazole; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanocapsules; Neovascularization, Pathologic; Particle Size; Phosphorylcholine; Random Allocation

2021
Itraconazole Induces Regression of Infantile Hemangioma via Downregulation of the Platelet-Derived Growth Factor-D/PI3K/Akt/mTOR Pathway.
    The Journal of investigative dermatology, 2019, Volume: 139, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Endothelial Cells; Gene Expression Profiling; Hemangioma; Humans; Itraconazole; Lymphokines; Mice; Neovascularization, Pathologic; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Platelet-Derived Growth Factor; Signal Transduction; TOR Serine-Threonine Kinases

2019
Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer.
    Cancer research, 2011, Nov-01, Volume: 71, Issue:21

    Topics: Adenocarcinoma; Aged; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cells, Cultured; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Itraconazole; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neovascularization, Pathologic; Xenograft Model Antitumor Assays

2011
Synergistic inhibition of endothelial cell proliferation, tube formation, and sprouting by cyclosporin A and itraconazole.
    PloS one, 2011, Volume: 6, Issue:9

    Topics: Antifungal Agents; Cell Proliferation; Cell Survival; Collagen; Cyclosporine; Drug Combinations; Drug Synergism; Endothelial Cells; Fibroblasts; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Itraconazole; Jurkat Cells; Laminin; Neovascularization, Pathologic; Proteoglycans; Signal Transduction; Time Factors

2011
The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells.
    The Journal of biological chemistry, 2011, Dec-23, Volume: 286, Issue:51

    Topics: Antifungal Agents; Biotinylation; Cell Line; Cell Proliferation; Endothelial Cells; Glycosylation; Humans; Itraconazole; Models, Biological; Neovascularization, Pathologic; Polysaccharides; Signal Transduction; Sterols; Vascular Endothelial Growth Factor Receptor-2

2011
Itraconazole inhibits HMEC-1 angiogenesis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2012, Volume: 66, Issue:4

    Topics: Adult; Angiogenesis Inhibitors; Antifungal Agents; Cell Line; Cholesterol; Endothelial Cells; Humans; Itraconazole; Microtubules; Microvessels; Neovascularization, Pathologic

2012
Itraconazole: its possible role in inhibiting angiogenesis in rheumatoid arthritis.
    Medical hypotheses, 2012, Volume: 79, Issue:3

    Topics: Arthritis, Rheumatoid; Humans; Itraconazole; Models, Theoretical; Neovascularization, Pathologic; Randomized Controlled Trials as Topic; Vascular Endothelial Growth Factor A

2012
Inhibition of angiogenesis by the antifungal drug itraconazole.
    ACS chemical biology, 2007, Apr-24, Volume: 2, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Antifungal Agents; Cattle; Cell Cycle; Cell Line; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Drug Evaluation, Preclinical; Endothelium, Vascular; Female; Humans; Itraconazole; Jurkat Cells; Male; Mice; Neovascularization, Pathologic; Oxidoreductases; Stereoisomerism; Sterol 14-Demethylase

2007